1. Market Research
  2. > Advanced IT Market Trends
The Future of Medical Affairs

The Future of Medical Affairs

  • December 2016
  • ID: 4833533
  • Format: PDF
  • Firstword Pharma

Summary

Table of Contents

Description

What are the future opportunities and challenges for medical affairs

As the interface between companies and KOLs, HCPs, payers and patients, medical affairs has grown rapidly in importance. And demands are set to grow with a wider number of stakeholders needing ever more specific data, information and support. How will medical affairs professionals meet evolving stakeholder expectations and prove to colleagues the critical value they play in pharma’s outreach?

Report Overview
In this strategic report, The Future of Medical Affairs, senior medical affairs experts from leading pharma companies peer into the crystal ball to identify the future challenges innovative practices and technologies that will shape future operations in this critical sector.

Report Features
- In-depth interviews reveal unique and frank insights from medical affairs experts in the US and EU
- Chart showing Medical affairs’ insight cycle
- Chart showing opportunities for digital engagement
- At-a-glance summaries of all the main insights.

Key Benefits
- Understand the growing external and internal challenges impacting medical affairs and its development as a distinct and professional discipline
- Investigate the trends and developments that are driving the expansion of medical affairs
- Learn how and why organisational strutures vary when it comes to medical affairs
- Assess the impact digital technology and big data will have on medical affairs operations and identify areas for action
- Formulate plans to challenge negative internal perceptions about medical affairs and gain support for the critical role it will play
- Size up the challenges facing the recruitment of experienced personnel as the medical affairs discipline grows
- Appraise options for measuring medical affairs success and proving value to colleagues.

Key Questions Answered By This Report
- Management challenge: How can medical affairs professionals secure leadership support and budget to meet growing demands?
- Professional: In what ways can medical affairs challenge internal perceptions and be seen as a professional discipline of strategic importance rather than a support function?
- Going digital: Digital technology is expected to revolutionise medical affairs practice but does this signal the end of traditional channels of communication?
- Staffing: What capabilities will medical affairs need in the future and how will this impact recruitment and team building?
- Valued added: What role will medical affairs play in the development of value-added services?
- In or out? What trends support the view that HEOR teams should be part of medical affairs?

Expert Views
To ensure candid views were expressed, some expert names have been kept anonymous, but each has been selected for their experience and detailed current knowledge of medical affairs.

- Dr Danie du Plessis. As Senior Vice President, Head of Worldwide Medical Affairs, Danie is accountable for medical affairs and governance across the Europe, Emerging Markets & Australasia, China, US and Japan regions and is based at GSK House in the UK. He previously worked for Eli Lilly & Company for 17 years in different roles and different therapeutic areas.
- Jeff New, Associate Director, Medical Affairs Business Operations, Lundbeck, USA. Jeff has over 17 years’ experience in medical affairs and has worked for Chelsea Therapeutics, Dey Labs, Bertek Pharmaceuticals, Takeda Pharmaceuticals, and PPD in medical information, publications, and field medical operations.
- Usman Iqbal, Senior Medical Affairs Leader – Neuroscience, Global Medical Affairs, AstraZeneca. Usman has 12+ years of healthcare experience, including clinical medicine, HEOR, global medical affairs and R&D in academia and the biopharmaceutical industry.
- Michael Zaiac is Vice President, Medical Affairs, Hematology/Oncology at Celgene EMEA. Michael’s responsibilities encompass medical information, scientific communication and education, collaborative data generation and Celgene-sponsored studies operated by Medical Affairs across Celgene’s hematology and oncology franchises.
- Executive Medical Director, Medical Affairs, Top 10 Pharma Company, USA
- Digital Events Lead, Global Medical Affairs, Top 10 Pharma Company,USA
- Director, Biotech Company, USA

Key Quotes
- “I think HEOR data is growing in its importance. I still see us utilising the same types of skills that we have currently with MSLs. But as HEOR information becomes more important, we'll either need to provide that skill set and understanding through training or specifically hire for. We have MSLs that are in some cases very focused on a particular disease state. I think they'll need to have a wider understanding of the healthcare system and the impact that that disease state or therapeutic option has on the wider organisation. I think it will require more budget, because some of this shift in focus to HEOR data will require financial investment. Companies will need to produce and deliver that data and, whether HEOR is within medical affairs or not, it will require some funds.”
- Jeff New, Associate Director, Medical Affairs Business Operations

- “Behind the scenes, everybody's talking about transforming medical affairs and making it into a real value-based function. So, the path is there but this level of discussion won't happen because there are very few elements in the workforce that have the level of skills and competency to be able to talk on an integrated, strategic level, in terms of what medical affairs can offer and enhance its value in today's evolving healthcare landscape. One of the biggest issues that medical affairs faces is skill development and harnessing talent within the function.”
- Usman Iqbal, Senior Medical Affairs Leader

- “I believe whether digital technology will be used more for communication will depend on the prevailing culture amongst the customers you serve and within your company. For instance, a company like Celgene is very much a face-to-face company. I don’t think we would replace this through digital technology, but we may want to add novel technology, e.g. virtual advisory boards when appropriate. The effect of this on medical affairs is potentially a capacity enhancer because you can do more advisory boards with this virtual technology, but it will depend on the therapeutic area and the kind of culture the company has.”
- Michael Zaiac, VP Medical Affairs

Who Would Benefit from This Report?
- Medical affairs teams gathering data and initiating programmes to inform physicians, payers and patients
- HEOR professionals working in or with medical affairs
- Commercial teams needing to understand the value medical affairs can bring to their work
- MSL teams needing to share the latest science and trial datato KOLs and physicians
- Company leaders needing ensure appropriate support and funding for medical affairs
- Market research and post marketing surveillance teams analysing long term real world data for medical affairs use

Content Highlights
KEY FUNCTIONS MEDICAL AFFAIRS
- Overarching objectives
- Medical affairs role as the bridge between company and stakeholders
- Key challenges for medical affairs
- Establishing and professionalising medical affairs
- Access to physicians
- Demonstrating the value of medicines to external stakeholders
- Demonstrating value to the company

TRENDS INFLUENCING MEDICAL AFFAIRS TEAMS
- Adapting to a changing working environment
- Team structure and growth potential
- Capability building
- Field Medical Teams
- Health economic and outcomes research
- Harnessing digital technology for communication
- Multichannel engagement
- Virtual advisory boards
- Medical education
- Partnering with medical societies
- Healthcare portals
- Virtual access to medical affairs
- Social media: challenge and opportunity
- Data collection and analytics
- Using big data to identify and segment KOLs
- Big data for non-interventional studies and analysis
- Collecting data from beyond the pill solutions
- Medical affairs to play a bigger role in the future

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2016

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on